Insider Trading History of Clarus Ventures Ii, Llc

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Clarus Ventures Ii, Llc since 2013. The trader's CIK number is 1431437. At the time of the last reporting, Clarus Ventures Ii, Llc was the 10% Owner of Nanostring Technologies Inc. (stock ticker symbol NSTG). Also see all insider trading activities at Nanostring Technologies Inc.

Note that in the past Clarus Ventures II, LLC also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Nanostring Technologies Inc (NSTG) by Clarus Ventures Ii, Llc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 NSTG 0 $0 85,823 $1,372,309 0 $0
2013 NSTG 750,000 $7,500,000 0 $0 0 $0

Yearly summary of insider trading at Catabasis Pharmaceuticals Inc (CATB) by Clarus Ventures Ii, Llc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 CATB 376,695 $4,520,340 0 $0 0 $0


Insider trading activities at 2 companies by Clarus Ventures Ii, Llc:

1. Nanostring Technologies Inc (NSTG)

2. Catabasis Pharmaceuticals Inc (CATB)

Table 1. Insider trading of Nanostring Technologies Inc (NSTG) by Clarus Ventures Ii, Llc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-09-17 NSTG Sale 85,823 15.99 1,372,309
2013-07-01 NSTG Buy 750,000 10.00 7,500,000

Table 2. Insider trading of Catabasis Pharmaceuticals Inc (CATB) by Clarus Ventures Ii, Llc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-06-30 CATB Buy 376,695 12.00 4,520,340

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Clarus Ventures Ii, Llc (10% Owner of Nanostring Technologies Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.